HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Zepbound reduced heart failure risk in a late-stage study

Gokhan Can · Aug 01, 2024 · ♥ 8 reactions · 8 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Heart rhythm & heart failureWeight, visceral & liver fat
AI summary & key facts

Gokhan says weight loss is the best drug in obesity and new GLP-1 drugs can aid it, sharing a CNBC report that Eli Lilly's Zepbound cut heart failure risk in a late-stage study, adding to evidence of benefits beyond weight and glucose control.

Weight loss is the best drug if you're obese. New GLP1 drugs can be a significant aid.

CNBCEli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage studyThe data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.cnbc.com

Research cited

#heartfailure#weightloss#glp1
← newer: Essential labs for heart disease prevention: lipids, hs-CRP,older: Personal note: covid after a long flight, plan to take Paxlo →